United States · Bill · HR
H.R. 1285 (113th)
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Introduced
20 March 2013
Last action
15 April 2013 · Referred
Status
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, And Investigations.
Sponsors
Rep. Buchanan, Vern [R-FL-16], Sen. Markey, Edward J. [D-MA], Sen. Capito, Shelley Moore [R-WV], Rep. Diaz-Balart, Mario [R-FL-26], Rep. Duncan, John J., Jr. [R-TN-2], Rep. Mica, John L. [R-FL-7], Rep. Roe, David P. [R-TN-1], Rep. Rogers, Harold [R-KY-5], Rep. Rooney, Thomas J. [R-FL-17], Rep. Ros-Lehtinen, Ileana [R-FL-27], Rep. Brown, Corrine [D-FL-5], Rep. Cooper, Jim [D-TN-5], Rep. Edwards, Donna F. [D-MD-4], Rep. Hastings, Alcee L. [D-FL-20], Rep. Keating, William R. [D-MA-9], Rep. Lynch, Stephen F. [D-MA-8], Rep. Rahall, Nick J., II [D-WV-3], Rep. Wilson, Frederica S. [D-FL-24], Rep. Kennedy, Joseph P., III [D-MA-4], Rep. Murphy, Patrick [D-FL-18], Rep. Castor, Kathy [D-FL-14], Rep. DesJarlais, Scott [R-TN-4], Rep. Fincher, Stephen Lee [R-TN-8], Rep. Miller, Jeff [R-FL-1], Rep. Nugent, Richard B. [R-FL-11], Rep. Tiberi, Patrick J. [R-OH-12], Rep. Issa, Darrell [R-CA-48], Rep. Deutch, Theodore E. [D-FL-22], Rep. Posey, Bill [R-FL-8], Rep. Black, Diane [R-TN-6], Rep. Pearce, Stevan [R-NM-2], Rep. Marino, Tom [R-PA-10], Rep. Slaughter, Louise McIntosh [D-NY-25], Rep. Westmoreland, Lynn A. [R-GA-3], Rep. Stivers, Steve [R-OH-15], Rep. Benishek, Dan [R-MI-1], Rep. Crenshaw, Ander [R-FL-4], Rep. Ross, Dennis A. [R-FL-15], Rep. Higgins, Brian [D-NY-26], Rep. Southerland, Steve II [R-FL-2], Rep. Tipton, Scott R. [R-CO-3], Rep. Shuster, Bill [R-PA-9], Rep. Miller, Candice S. [R-MI-10], Rep. Davis, Rodney [R-IL-13], Rep. Schock, Aaron [R-IL-18], Rep. Camp, Dave [R-MI-4], Rep. McCarthy, Carolyn [D-NY-4], Rep. Garcia, Joe [D-FL-26]
Subjects
Discovery layer
Source updated
8 December 2025
Summary
Amends the Controlled Substances Act to remove dihydrocodeinone (hydrocodone) from classification as a schedule III controlled substance. Directs the Attorney General to immediately allow manufacturers and distributors to store hydrocodone compound products in accordance with the physical security requirements for schedule III, IV, and V controlled substances for three years beginning on the date enactment of this Act. Requires the Comptroller General to submit a report on the reclassification of hydrocodone products under this Act, including: (1) an assessment of the degree to which the reclassification of such products under this Act impacts the ability of patients with legitimate medical needs, particularly those in rural areas and nursing home facilities, to access adequate pain management; and (2) recommendations necessary to address any issues relating to patient access to adequate pain management.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
20 March 2013
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
20 March 2013
Introduced
Introduced in House
Source: IntroReferral
20 March 2013
Introduced
Introduced in House
Source: IntroReferral
22 March 2013
Referred
Referred to the Subcommittee on Health.
Source: Committee
15 April 2013
Referred
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, And Investigations.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 20 March 2013 · Download file
Documents
3 official files
Introduced in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 20 March 2013
Introduced in House (PDF)
Introduced in House · EN · 20 March 2013
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 20 March 2013
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Buchanan, Vern [R-FL-16] · R · Sponsor
- Sen. Markey, Edward J. [D-MA] · D · Sponsor
- Sen. Capito, Shelley Moore [R-WV] · R · Sponsor
- Rep. Diaz-Balart, Mario [R-FL-26] · R · Sponsor
- Rep. Duncan, John J., Jr. [R-TN-2] · R · Sponsor
- Rep. Mica, John L. [R-FL-7] · R · Sponsor
- Rep. Roe, David P. [R-TN-1] · R · Sponsor
- Rep. Rogers, Harold [R-KY-5] · R · Sponsor
- Rep. Rooney, Thomas J. [R-FL-17] · R · Sponsor
- Rep. Ros-Lehtinen, Ileana [R-FL-27] · R · Sponsor
- Rep. Brown, Corrine [D-FL-5] · D · Sponsor
- Rep. Cooper, Jim [D-TN-5] · D · Sponsor
- Rep. Edwards, Donna F. [D-MD-4] · D · Sponsor
- Rep. Hastings, Alcee L. [D-FL-20] · D · Sponsor
- Rep. Keating, William R. [D-MA-9] · D · Sponsor
- Rep. Lynch, Stephen F. [D-MA-8] · D · Sponsor
- Rep. Rahall, Nick J., II [D-WV-3] · D · Sponsor
- Rep. Wilson, Frederica S. [D-FL-24] · D · Sponsor
- Rep. Kennedy, Joseph P., III [D-MA-4] · D · Sponsor
- Rep. Murphy, Patrick [D-FL-18] · D · Sponsor
- Rep. Castor, Kathy [D-FL-14] · D · Sponsor
- Rep. DesJarlais, Scott [R-TN-4] · R · Sponsor
- Rep. Fincher, Stephen Lee [R-TN-8] · R · Sponsor
- Rep. Miller, Jeff [R-FL-1] · R · Sponsor
- Rep. Nugent, Richard B. [R-FL-11] · R · Sponsor
- Rep. Tiberi, Patrick J. [R-OH-12] · R · Sponsor
- Rep. Issa, Darrell [R-CA-48] · R · Sponsor
- Rep. Deutch, Theodore E. [D-FL-22] · D · Sponsor
- Rep. Posey, Bill [R-FL-8] · R · Sponsor
- Rep. Black, Diane [R-TN-6] · R · Sponsor
- Rep. Pearce, Stevan [R-NM-2] · R · Sponsor
- Rep. Marino, Tom [R-PA-10] · R · Sponsor
- Rep. Slaughter, Louise McIntosh [D-NY-25] · D · Sponsor
- Rep. Westmoreland, Lynn A. [R-GA-3] · R · Sponsor
- Rep. Stivers, Steve [R-OH-15] · R · Sponsor
- Rep. Benishek, Dan [R-MI-1] · R · Sponsor
- Rep. Crenshaw, Ander [R-FL-4] · R · Sponsor
- Rep. Ross, Dennis A. [R-FL-15] · R · Sponsor
- Rep. Higgins, Brian [D-NY-26] · D · Sponsor
- Rep. Southerland, Steve II [R-FL-2] · R · Sponsor
- Rep. Tipton, Scott R. [R-CO-3] · R · Sponsor
- Rep. Shuster, Bill [R-PA-9] · R · Sponsor
- Rep. Miller, Candice S. [R-MI-10] · R · Sponsor
- Rep. Davis, Rodney [R-IL-13] · R · Sponsor
- Rep. Schock, Aaron [R-IL-18] · R · Sponsor
- Rep. Camp, Dave [R-MI-4] · R · Cosponsor
- Rep. McCarthy, Carolyn [D-NY-4] · D · Cosponsor
- Rep. Garcia, Joe [D-FL-26] · D · Cosponsor
Showing 48 of 57 sponsors and actors.
Related records
- related to ← Safe Prescribing Act of 2013
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/113th-congress/house-bill/1285
- Open data entity: https://api.congress.gov/v3/bill/113/hr/1285
- us · 113-hr-1285 · source updated 8 December 2025